Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic lateral sclerosis (ALS) access to the experimental drug ibudilast over six months.
Neurocrine reports a second PhIII success in congenital adrenal hyperplasia, this time in children
Neurocrine Biosciences said its treatment for congenital adrenal hyperplasia (CAH) — a genetic disorder that causes hormone imbalance — helped reduce the daily dose of
October 6, 2023